Chapter 35 - DRUG UTILIZATION REVIEW
- Section 12-15-35-1 - "Appropriate and medically necessary" defined
- Section 12-15-35-2 - "Board" defined
- Section 12-15-35-3 - "Compendia" defined
- Section 12-15-35-4 - "Counseling" defined
- Section 12-15-35-4.5 - "Covered outpatient drug" defined
- Section 12-15-35-5 - "Criteria" defined
- Section 12-15-35-6 - "Drug-disease contraindication" defined
- Section 12-15-35-7 - "Drug-drug interaction" defined
- Section 12-15-35-8 - "Drug utilization review" or "DUR" defined
- Section 12-15-35-9 - "Intervention" defined
- Section 12-15-35-10 - "Overutilization or underutilization" defined
- Section 12-15-35-11 - "Pharmacist" defined
- Section 12-15-35-12 - "Physician" defined
- Section 12-15-35-13 - "Prospective DUR" defined
- Section 12-15-35-14 - "Retrospective DUR" defined
- Section 12-15-35-15 - "Standards" defined
- Section 12-15-35-16 - "SURS" defined
- Section 12-15-35-17 - "Therapeutic appropriateness" defined
- Section 12-15-35-17.5 - "Therapeutic classification" or "therapeutic category" defined
- Section 12-15-35-18 - "Therapeutic duplication" defined
- Section 12-15-35-18.5 - Application of chapter
- Section 12-15-35-18.7 - Formulary requirements
- Section 12-15-35-19 - Drug utilization review board; establishment
- Section 12-15-35-20 - Membership of board
- Section 12-15-35-20.1 - Conflicts of interest
- Section 12-15-35-20.5 - Therapeutics committee established; members; limitations; terms; votes; meetings
- Section 12-15-35-21 - Board; appointment; term
- Section 12-15-35-22 - Qualifications of board members
- Section 12-15-35-23 - Physician appointments; geographic balance
- Section 12-15-35-24 - Reappointment of members
- Section 12-15-35-25 - Chairman; compensation; expenses
- Section 12-15-35-26 - Additional staff
- Section 12-15-35-27 - Retrospective and prospective DUR program responsibility
- Section 12-15-35-28 - Duties of the board; preferred drug list; report
- Section 12-15-35-28.5 - Therapeutics committee duties
- Section 12-15-35-28.7 - Submitting initial preferred drug list; limitations on restrictions; advance notice to providers; implementation; prior authorization limitation; rules
- Section 12-15-35-29 - Quorum; majority vote on DUR criteria and standards for prescribing
- Section 12-15-35-30 - Local practices; monitoring
- Section 12-15-35-31 - Intervention; approval; requisites
- Section 12-15-35-32 - [Repealed]
- Section 12-15-35-32.1 - Annual report contents
- Section 12-15-35-33 - [Repealed]
- Section 12-15-35-34 - Confidential identifying information; release of cumulative nonidentifying information
- Section 12-15-35-35 - Prior approval program for outpatient drugs; standards
- Section 12-15-35-36 - Advisory committees
- Section 12-15-35-37 - Medicaid state plan; inclusion of retrospective and prospective DUR program
- Section 12-15-35-38 - DUR program guidelines and procedures
- Section 12-15-35-39 - Retrospective DUR requisites
- Section 12-15-35-40 - Prospective DUR requisites
- Section 12-15-35-41 - Board activities under IC 34-30-15
- Section 12-15-35-42 - Meetings
- Section 12-15-35-43 - Confidentiality; pharmacist data and information
- Section 12-15-35-43.5 - Prohibiting the release of proprietary or confidential information obtained under certain circumstances
- Section 12-15-35-44 - Confidentiality; violations; penalty
- Section 12-15-35-45 - Outpatient drug formulary; requirements
- Section 12-15-35-46 - Review of proposed formulary
- Section 12-15-35-47 - Review of changes to formulary
- Section 12-15-35-48 - Board review of managed care organization prescription drug program
- Section 12-15-35-49 - Information provided by office
- Section 12-15-35-50 - Maximum allowable cost schedule for drugs; pharmacy participation in Medicaid program
- Section 12-15-35-51 - Advisory committee; duties; report